For the Inventor, By the Inventor

Enter assignee name

Dartmouth, Canada

Immunovaccine Technologies Inc.

USPTO Granted Patents = 20

% Expired Patents = 35.0

CIPO Patents = 18

EPO Patents = 6

Trademarks = 3

Forward Citations = 113

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Marc Mansour (15 out of 16 patents)

Genevieve Mary Weir (12 out of 12 patents)

Leeladhar Sammatur (7 out of 8 patents)

4. Robert George Brown (7 out of 10 patents)

5. Marianne Michelle Stanford (6 out of 6 patents)

6. Bill Pohajdak (6 out of 11 patents)

7. Lisa Diana MacDonald (5 out of 6 patents)

8. Mohan Karkada (4 out of 4 patents)

9. Warwick Charles Kimmins (4 out of 6 patents)

10. Rajkannan Rajagopalan (3 out of 4 patents)

11. Frederic Ors (2 out of 7 patents)

12. Kendall Sharp (2 out of 2 patents)

13. Jordan David Lewicky (2 out of 2 patents)

14. Zi-hua Jiang (2 out of 3 patents)

15. Neil L Berinstein (2 out of 12 patents)

20 patents: Sort by Forward Citations

1. 11717563 - Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance (2023-08-08),

2. 11406705 - Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects (2022-08-09),

3. 11260116 - Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof (2022-03-01),

4. 11235069 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2022-02-01),

5. 11160861 - Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant (2021-11-02),

6. 11077184 - Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response (2021-08-03),

7. 10988500 - Lipid A mimics, methods of preparation, and uses thereof (2021-04-27),

8. 10729766 - Method for improving the efficacy of a survivin vaccine in the treatment of cancer (2020-08-04),

9. 10533033 - Lipid A mimics, methods of preparation, and uses thereof (2020-01-14),

10. 10272042 - Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment (2019-04-30),

11. 10232052 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2019-03-19),

12. 10105435 - Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof (2018-10-23),

13. 10022441 - Method for improving the efficacy of a survivin vaccine in the treatment of cancer (2018-07-17),

14. 9925142 - Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment (2018-03-27),

15. 9498493 - Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo (2016-11-22),

Company Overview

Immunovaccine Technologies Inc. is a biotechnology company based in Dartmouth, Canada, specializing in the development of innovative immunotherapies for cancer and infectious diseases. The company focuses on harnessing its proprietary vaccine platform to create targeted therapies that enhance the immune response. With a commitment to advancing healthcare solutions, Immunovaccine is dedicated to improving patient outcomes through cutting-edge research and development in the field of immunology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#3 in Dartmouth

#725 in Canada

#31,295 in the World

Dartmouth, Canada

Immunovaccine Technologies Inc.

Forward Citations = 113

21 inventors:

Marc Mansour (15 out of 16 patents)

Genevieve Mary Weir (12 out of 12 patents)

Leeladhar Sammatur (7 out of 8 patents)

4. Robert George Brown (7 out of 10 patents)

5. Marianne Michelle Stanford (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunovaccine Technologies Inc.. Retrieved from https://idiyas.com/company/immunovaccine-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…